Learn how to build a smarter lab equipment budget that supports growth, flexibility, and long-term savings.
Avoid costly lab buildout delays by learning the top causes—and how leasing can help speed up your setup.
Discover the true cost of owning lab equipment and explore ways to cut expenses without compromising quality.
NewLimit raises $45M to advance epigenetic reprogramming therapies targeting cellular aging—Excedr covers this major biotech funding round.
Pelage Pharmaceuticals raises $120M Series B for PP405 stem cell therapy in hair loss—Excedr covers this major biotech funding round.
Peptilogics raises $78M to develop AI-designed peptides for joint infections—Excedr covers this major biotech funding round.
Weave Bio’s $20M Series A accelerates AI automation in drug regulatory workflows—Excedr covers this major biotech funding round.
Exactics pioneers rapid, at-home infectious disease tests with its adaptable Proteus+ platform—Excedr covers this major biotech funding round.
Bexorg transforms CNS drug discovery with AI-powered whole-human brain platform—Excedr covers this major biotech funding round.
Lila Sciences pioneers autonomous AI labs, raising $550M to build scientific superintelligence—Excedr covers this major biotech funding round.
